Tumor-necrosis-factor-Gene-α-deficient mice have improved cardiac function through reduction of intercellular adhesion molecule-1 in myocardial infarction

Circulation Journal

Volumn 70, Issue 12, 2006, Pages 1635-1642

  Sato, Takatoshi ^a   Suzuki, Hiroshi ^a   Shibata, Masayuki ^a   Kusuyama, Taro ^a   Omori, Yasutoshi ^a   Soda, Teruko ^a   Shoji, Makoto ^a   Iso, Yoshitaka ^a   Koba, Shinji ^a   Geshi, Eiichi ^a   Katagiri, Takashi ^a   Shioda, Seiji ^a   Sekikawa, Kenji ^b,c  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF AGROBIOLOGICAL SCIENCES   (Japan)

^c KITASATO UNIVERSITY   (Japan)

Author keywords

Intercellular adhesion molecule 1; Myocardial infarction; Nitric oxide; Tumor necrosis factor

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; C57BL MOUSE; ECHOCARDIOGRAPHY; HEART; HEART INFARCTION; HEART MUSCLE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MACROPHAGE; MALE; METABOLISM; MOUSE; MOUSE MUTANT; NEUTROPHIL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ECHOCARDIOGRAPHY; HEART; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; MYOCARDIUM; NEUTROPHILS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 39049177620     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.70.1635     Document Type: Article

References (39)

1. Herskowitz A, Choi S, Ansari AA, Wesselingh S. Cytokine mRNA expression in postischemic/reperfused myocardium. Am J Pathol 1995; 146: 419-428.
2. Neumann FJ, Ott I, Gawaz M, Richardt G, Holzapfel H, Jochum M, et al. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 1995; 92: 748-755.
3. Frangogiannis NG, Lindsey ML, Michael LH, Youker KA, Bressler RB, Mendoza LH, et al. Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion. Circulation 1998; 98: 699-710.
4. Kupatt C, Habazettl H, Goedecke A, Wolf DA, Zahler S, Boekstegers P, et al. Tumor necrosis factor-alpha contributes to ischemia and reperfusion-induced endothelial activation in isolated hearts. Circ Res 1999; 84: 392-400.
5. Min WI, Susanna M, Douglas LM, Rong Q, Josef MP, Andrew Y, et al. Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium. Circulation 1999; 99: 1492-1498.
6. Levine B, Kalman J, Mayer L, Fillit H, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 323: 236-241.
7. Setsuta K, Seino Y, Ogawa T, Ohtsuka T, Semiya K, Takano T. Ongoing myocardial damage in chronic heart failure is related to activate tumor necrosis factor and Fas/Fas ligand system. Circ J 2004; 68: 747-750.
8. Torre-Amione G, Kapadia S, Lee J, Durand JD, Bies RD, Young JB, et al. Tumor necrosis factor alpha and tumor necrosis factor receptors in the failing human heart. Circulation 1996; 93: 704-711.
9. + current in cultured neonatal rat cardiomyocytes: A possible cause of electrical remodeling in diseased hearts. Circ J 2006; 70: 605-609.
10. Suwannaprapha P, Chaisri U, Riyong D, Maneerat D. Improvement of function and morphology of tumor necrosis factor-alpha treated endothelial cells with 17-beta estradiol: A preliminary study for a feasible simple model for atherosclerosis. Circ J 2005; 69: 730-738.
11. Kapadia SR, Oral H, Lee J, Nakano M, Taffet GE, Mann DL. Hemodynamic regulation of tumor necrosis factor-alpha gene and protein expression in adult feline myocardium. Circ Res 1997; 81: 187-195.
12. Bryant D, Becker L, Richardson J, Shelton J, Franco F, Peshock R, et al. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Circulation 1998; 97: 1375-1381.
13. Gurevitch J, Frolkis I, Yuhas Y, Lifschitz-Mercer B, Berger E, Paz Y, et al. Anti-tumor necrosis factor-alpha improves myocardial recovery after ischemia and reperfusion. J Am Coll Cardiol 1997; 30: 1554-1561.
14. Sugano M, Hata T, Tsuchida K, Suematsu N, Oyama J, Satoh S, et al. Local delivery of soluble TNF-alpha receptor 1 gene reduces infarct size following ischemia/reperfusion injury in rats. Mol Cell Biochem 2004; 266: 127-132.
15. Maekawa N, Wada H, Kanda T, Niwa T, Yamada Y, Saito K, et al. Improved myocardial ischemia/reperfusion injury in mice lacking tumor necrosis factor-alpha. J Am Coll Cardiol 2002; 39: 1229-1235.
16. Eddy LJ, Goeddel V, Wong GH. Tumor necrosis factor-alpha pretreatment is protective in a rat model of myocardial ischemia-reper fusion injury. Biochem Biophys Res Commun 1992; 184: 1056-1059.
17. Kurrelmeyer KM, Michael LH, Baumgarten G, Taffet GE, Peschon JJ, Sivasubramanian N, et al. Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. Proc Natl Acad Sci USA 2000; 97: 5456-5461.
18. Sun M, Dawood F, Wen W-H, Chen M, Dixon I, Kirshenbaum LA, et al. Excessive tumor necrosis factor activation after infarction contributes to susceptibility of myocardial rupture and left ventricular dysfunction. Circulation 2004; 110: 3221-3228.
19. Issekutz AC, Rowter D, Springer TA. Role of ICAM-1 and ICAM-2 and alternate CD11/CD18 ligands in neutrophil transendothelial migration. J Leukoc Biol 1999; 65: 117-126.
20. McEver RP. Leukocyte endothelial cell interactions. Curr Opin Cell Biol 1992; 4: 840-849.
21. Entman ML, Youker K, Shoji T, Kukielka GL, Shappel SB, Taylor AA, et al. Neutrophil-induced oxidative injury of cardiac myocytes: A compartmented system requiring CD11b/CD18-ICAM-1 adherence. J Clin Invest 1992; 90: 1335-1345.
22. Frenette PS, Wagner DD. Adhesion molecules, blood vessels and blood cells. N Engl J Med 1996; 335: 43-45.
23. Graciano AL, Bryant DD, White DJ, Horton J, Bowles NE, Giroir BP. Targeted disruption of ICAM-1, -selectin genes improves cardiac function and survival in TNF-alpha transgenic mice. Am J Physiol Heart Circ Physiol 2001; 280: H1464-H1471.
24. Taniguchi T, Takata M, Ikeda A, Momotani E, Sekikawa K. Failure of germinal center formation and impairment of response to endotoxin in tumor necrosis factor alpha-deficient mice. Lab Invest 1997; 77: 647-655.
25. Kubota T, Bounoutas GS, Miyagishima M, Kadokami T, Sanders VJ, Bruton C, et al. Soluble tumor necrosis factor receptor abrogates myocardial inflammation but not hypertrophy in cytokine-induced cardiomyopathy. Circulation 2000; 101: 2518-2525.
26. Simpson PJ, Todd RF, Fontane JC, Michelson JK, Griffin JD, Lucchesi BR. Reduction of experimental cannine myocardial reperfusion injury by a monoclonal antibody (anti-Mol, anti-CD11b) that inhibits leukocyte adhesion. J Clin Invest 1998; 81: 624-649.
27. Simpson PJ, Todd RF, Mickelson JK, Fantone JC, Gallagher KP, Lee KA, et al. Sustained limitation of myocardial reperfusion injury by a monoclonal antibody that alters leukocyte function. Circulation 1990; 81: 226-237.
28. Palazzo AJ, Jones SP, Girod WG, Anderson DC, Granger DN, Lefer DJ. Myocardial ischemia-reperfusion injury in CD18-and ICAM-1-deficiency mice. Am J Physiol 1998; 275: H2300-H2307.
29. Youker K, Smith CW, Anderson DC, Miller D, Michael LH, Rossen RD, et al. Neutrophil adherence to isolated cardiac myocytes: Induction by cardiac lymph collected during ischemia and reperfusion. J Clin Invest 1992; 89: 602-606.
30. Wada H, Saito K, Kanda T, Kobayashi I, Fujii H, Fujigaki S, et al. Tumor necrosis factor-alpha plays a protective role in acute viral myocarditis in mice. Circulation 2001; 103: 743-749.
31. Eichenholz PW, Eichacker PQ, Hoffman WD, Banks SM, Parrillo JE, Danner RL, et al. Tumor necrosis factor challenges in canines: Patterns of cardiovascular dysfunction. Am J Physiol 1992; 263: H668-H675.
32. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992; 257: 387-389.
33. 2+-independent nitric oxide synthase in the myocardium. Br J Pharmacol 1992; 105: 575-580.
34. Schulz R, Panas DL, Catena R, Moncada S, Olley PM, Lopaschuk GD. The role of nitric oxide in cardiac depression induced by interleukin-1beta and tumor necrosis factor-alpha. Br J Pharmacol 1995; 114: 27-34.
35. Panas D, Khadour FH, Szabo C, Schulz R. Pro-inflammatory cytokines depress cardiac efficiency by a nitric oxide-dependent mechanism. Am J Physiol 1998; 275: H1016-H1023.
36. Sugamori T, Ishibashi Y, Shimada T, Takahashi N, Sakane T, Ohata S, et al. Increased nitric oxide in proportion to the severity of heart failure in patients with dilated cardiomyopathy: Close correlation of tumor necrosis factor-alpha with systemic and local production of nitric oxide. Circ J 2002; 66: 627-632.
37. Nagashima M, Itoh A, Otsuka M, Kasanuki H, Haze K. Reperfusion phenomenon is a strong predictor of left ventricular remodeling after acute myocardial infarction. Circ J 2005; 69: 884-889.
38. Hasegawa H, Takano H, Shiraishi H, Ueda K, Niitsuma Y, Tadokoro H, et al. Intracoronary injection of granulocyte colony-stimulating factor ameliorates the progression of left ventricular remodeling after myocardial ischemia/reperfusion in rabbits. Circ J 2006; 70: 942-944.
39. Ono K, Matsumori A, Shioji T, Furukawa Y, Sasayama S. Cytokine gene expression after myocardial infarction in rat hearts. Circulation 1998; 98: 149-156.